GlassScriptPhysician profile
Vasil Parousis
NPI 1881700540
$3,511.79
in general payments reported to CMS, 2019-2025
23 companies · $556 in 2025
The $556 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $338 · 2021: $244 · 2022: $822 · 2023: $494 · 2024: $677 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,726.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $754.65 | 2019-2024 | Myrbetriq |
| Pfizer INC. | $573.89 | 2019-2025 | |
| Abbvie INC. | $533.55 | 2020-2025 | |
| Boston Scientific Corporation | $511.13 | 2019-2025 | Ams 700, Solyx Sis System, General - Erectile Dysfunction |
| Sumitomo Pharma America, INC. | $390.08 | 2024-2025 | Orgovyx, Gemtesa |
| Allergan, INC. | $178.38 | 2020-2022 | |
| Dendreon Pharmaceuticals LLC | $82.35 | 2022 | |
| Teleflex LLC | $68.24 | 2024-2025 | Barrigel |
| Axonics, INC. | $63.94 | 2021-2024 | Axonics |
| Tolmar, INC. | $57.26 | 2023 | |
| Olympus America INC. | $40.66 | 2023 | Itind System, Double-J |
| Janssen Biotech, INC. | $34.47 | 2019-2022 | |
| Bioprotect Medical, INC. | $32.89 | 2025 | Bioprotect Balloon Implant System |
| Antares Pharma, INC. | $27.60 | 2025 | Xyosted |
| Tolmar Pharmaceuticals, INC. | $24.91 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $24.45 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $21.29 | 2023 | Interstim |
| Calyxo, INC. | $18.80 | 2024 | Cvac Aspiration System |
| Endo USA, INC. | $17.47 | 2024 | Xiaflex |
| 180 Medical, INC. | $14.52 | 2019 | |
| Neotract INC. | $14.15 | 2020 | |
| Ambu INC. | $14.12 | 2021 | |
| Acerus Pharmaceuticals Corporation | $12.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasil Parousis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.